使AIFDA

Scott Proestel1, Linda J B Jeng2, Christopher Smith1

  • 1Division of Biomedical Informatics, Research, and Biomarker Development, Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Evaluation and Research, FDA, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA.

概括

生成型人工智能 (AI) 可以帮助在FDA指导文件中找到信息,但准确性仍然是一个问题. 虽然人工智能可以引用来源,但在药物开发决策中完全信任它之前,需要进一步的研究.